Discover how advanced solutions are transforming LC-MS workflows - especially in high-throughput experimentation (HTE) by eliminating inefficiencies and enabling seamless AI/ML integration.

Catch up on HPLC 2025 highlights in this flashback webinar with expert talks, posters, and reports. Discover the new Vanquish CAD P Series and its advances in HPLC workflows.

Explore the evolution of Agilent LC/MS quadrupole instruments, from early designs to advanced systems shaping pharma, environmental, and food safety analysis.

See how CE-nanoESI-QQQ MS with 3D-printed interface enables attomole-level single-cell metabolomics, revealing neurotransmitters and metabolites in neurons.

Learn how HPLC/MS/MS quantifies hundreds of drugs from dried blood spots, with forensic data from 1,000+ paired DBS and urine samples using Agilent LC/QQQ.

Integrated targeted and untargeted metabolomics using Agilent LC/MS reveals key CRC-associated serum changes, enhancing biomarker discovery potential.

Discover the GIGA assay: a fully automated LC/MS/MS workflow on Agilent 6495D that quantifies 2000+ metabolites in under 20 minutes, enabling next-gen metabolomics.

Molecular You combines multi-omic LC/MS/MS assays, AI, and clinical data to deliver predictive health insights, guide therapies, and advance personalized medicine.

Discover how Nurix uses Agilent 6495 QqQ LC/MS MRM proteomics to quantify 45+ kinases, enabling high-throughput screening and degrader selectivity in TPD.

AbbVie, MassTech, and Agilent present a new AP-MALDI QqQ platform, delivering up to 200× greater sensitivity for targeted imaging and drug analysis.